Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 16, Issue 10, Pages 2816-2835Publisher
WILEY
DOI: 10.1111/ajt.13909
Keywords
-
Categories
Funding
- Medical Research Council [MR/J006742/1, MC_PC_15108] Funding Source: researchfish
- Grants-in-Aid for Scientific Research [15K08345] Funding Source: KAKEN
- Medical Research Council [MR/J006742/1, MC_PC_15108] Funding Source: Medline
Ask authors/readers for more resources
The Banff Working Group on Liver Allograft Pathology reviewed and discussed literature evidence regarding antibody-mediated liver allograft rejection at the 11th (Paris, France, June 5-10, 2011), 12th (Comandatuba, Brazil, August 19-23, 2013), and 13th (Vancouver, British Columbia, Canada, October 5-10, 2015) meetings of the Banff Conference on Allograft Pathology. Discussion continued online. The primary goal was to introduce guidelines and consensus criteria for the diagnosis of liver allograft antibody-mediated rejection and provide a comprehensive update of all Banff Schema recommendations. Included are new recommendations for complement component 4d tissue staining and interpretation, staging liver allograft fibrosis, and findings related to immunosuppression minimization. In an effort to create a single reference document, previous unchanged criteria are also included.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available